BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19074333)

  • 21. Decoding the dynamics of T cell-dendritic cell interactions in vivo.
    Celli S; Garcia Z; Beuneu H; Bousso P
    Immunol Rev; 2008 Feb; 221():182-7. PubMed ID: 18275482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cathepsins and compartmentalization in antigen presentation.
    Riese RJ; Chapman HA
    Curr Opin Immunol; 2000 Feb; 12(1):107-13. PubMed ID: 10679409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation.
    Germain RN
    Cell; 1994 Jan; 76(2):287-99. PubMed ID: 8293464
    [No Abstract]   [Full Text] [Related]  

  • 24. MHC II and the endocytic pathway: regulation by invariant chain.
    Landsverk OJ; Bakke O; Gregers TF
    Scand J Immunol; 2009 Sep; 70(3):184-93. PubMed ID: 19703008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The dendritic cell-like functions of IFN-producing killer dendritic cells reside in the CD11b+ subset and are licensed by tumor cells.
    Terme M; Mignot G; Ullrich E; Bonmort M; Minard-Colin V; Jacquet A; Schultze JL; Kroemer G; Leclerc C; Chaput N; Zitvogel L
    Cancer Res; 2009 Aug; 69(16):6590-7. PubMed ID: 19679551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracellular transport and peptide loading of MHC class II molecules: regulation by chaperones and motors.
    Wubbolts R; Neefjes J
    Immunol Rev; 1999 Dec; 172():189-208. PubMed ID: 10631947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory fragment from the p41 form of invariant chain can regulate activity of cysteine cathepsins in antigen presentation.
    Mihelic M; Dobersek A; Guncar G; Turk D
    J Biol Chem; 2008 May; 283(21):14453-60. PubMed ID: 18362148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigen presentation. DM exchange mechanism.
    Wolf PR; Ploegh HL
    Nature; 1995 Aug; 376(6540):464-5. PubMed ID: 7637776
    [No Abstract]   [Full Text] [Related]  

  • 29. Proteases, processing, and thymic selection.
    Cresswell P
    Science; 1998 Apr; 280(5362):394-5. PubMed ID: 9575085
    [No Abstract]   [Full Text] [Related]  

  • 30. Invariant chain transmembrane domain trimerization: a step in MHC class II assembly.
    Dixon AM; Stanley BJ; Matthews EE; Dawson JP; Engelman DM
    Biochemistry; 2006 Apr; 45(16):5228-34. PubMed ID: 16618111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activated pDCs: open to new antigen-presentation possibilities.
    van den Hoorn T; Neefjes J
    Nat Immunol; 2008 Nov; 9(11):1208-10. PubMed ID: 18936779
    [No Abstract]   [Full Text] [Related]  

  • 32. Nitric-oxide synthase 2 interacts with CD74 and inhibits its cleavage by caspase during dendritic cell development.
    Huang D; Cai DT; Chua RYR; Kemeny DM; Wong SH
    J Biol Chem; 2008 Jan; 283(3):1713-1722. PubMed ID: 18003616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunology: the pick of the nibbled bits.
    Swanson J
    Nature; 2006 Apr; 440(7085):750-1. PubMed ID: 16598243
    [No Abstract]   [Full Text] [Related]  

  • 34. Insight into the biology of macrophage migration inhibitory factor (MIF) revealed by the cloning of its cell surface receptor.
    Leng L; Bucala R
    Cell Res; 2006 Feb; 16(2):162-8. PubMed ID: 16474429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dendritic cells "in vivo": their role in the initiation of intestinal immune responses.
    Liu L; MacPherson GG
    Adv Exp Med Biol; 1995; 371A():271-4. PubMed ID: 8525923
    [No Abstract]   [Full Text] [Related]  

  • 36. Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation.
    Singh SK; Stephani J; Schaefer M; Kalay H; GarcĂ­a-Vallejo JJ; den Haan J; Saeland E; Sparwasser T; van Kooyk Y
    Mol Immunol; 2009 Dec; 47(2-3):164-74. PubMed ID: 19818504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ComPLEXIN new targets for CIITA.
    Reith W
    Nat Immunol; 2003 Sep; 4(9):819-20. PubMed ID: 12942078
    [No Abstract]   [Full Text] [Related]  

  • 38. Immortalized cell lines with dendritic morphology derived from mice lacking both type I and type II interferon receptors present MHC II restricted antigen to T cells and induce mixed leukocyte reactions.
    Nunez R; Ackermann M; Suter M
    Adv Exp Med Biol; 1997; 417():425-32. PubMed ID: 9286398
    [No Abstract]   [Full Text] [Related]  

  • 39. Taking the easy way out?
    Schuldt A
    Nat Cell Biol; 2002 Sep; 4(9):E213. PubMed ID: 12205483
    [No Abstract]   [Full Text] [Related]  

  • 40. Recent advances in antigen processing and presentation.
    Jensen PE
    Nat Immunol; 2007 Oct; 8(10):1041-8. PubMed ID: 17878914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.